June 24, 2022
Indivior, Aquestive and Dr. Reddy's Laboratories have ended their yearslong litigation battle over generic versions of the opioid addiction treatment Suboxone, with the Indian drugmaker on Friday saying it will receive $72 million by April 2024.
July 13, 2018
Determining that drugmaker Indivior will likely be able to show its suit claiming infringement by Dr. Reddy's of a so-called child patent covering its Suboxone Film will not be precluded by a suit in which Dr. Reddy's was cleared of infringement of the parent patent, a New Jersey federal judge on Friday granted Indivior a preliminary injunction blocking sales.
February 09, 2018
Indivior Inc. has filed several suits in New Jersey and Utah federal courts accusing Teva Pharmaceutical Inc., Actavis Laboratories UT Inc. and others of infringing a patent Indivior holds for Suboxone sublingual film, a drug used to treat opioid addiction.